What Researchers Did
Researchers prospectively investigated the feasibility of transferring low-pressure topical hyperbaric oxygen therapy technology to Health Maintenance Organization personnel for treating necrotic wounds.
What They Found
Among 15 patients with 24 necrotic wounds, 6 of 6 Level 2 wounds healed within 2 to 4 weeks, 9 of 10 Level 3 wounds healed within 4 to 10 weeks, and 7 of 8 Level 4 wounds healed within 4 to 12 weeks. Overall, ulcers improved by a mean of 0.829 cm2 per day (P < 0.0001), and wound healing with this therapy was associated with decreased costs.
What This Means for Canadian Patients
Canadian patients suffering from chronic, non-healing necrotic wounds might benefit from this low-pressure oxygen therapy as a potential treatment option. Successful implementation could lead to improved wound healing outcomes and potentially lower healthcare costs associated with prolonged standard care.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study was a small-scale feasibility study, limiting the generalizability of its findings.